Clinical trials
Completed Lymphoproliferative Disorders trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 5 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 5 |
| 2006 | 3 |
| 2007 | 5 |
| 2008 | 8 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 61 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seagen Inc. | 6 |
| Baylor College of Medicine | 5 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 5 |
| Alliance for Clinical Trials in Oncology | 3 |
| Children's Oncology Group | 3 |
| Mayo Clinic | 3 |
| Amgen Research (Munich) GmbH | 2 |
| Case Comprehensive Cancer Center | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
| National Cancer Institute (NCI) | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoproliferative Disorders | 61 |
| Lymphoma | 30 |
| Lymphoma, Non-Hodgkin | 28 |
| Lymphoma, Large B-Cell, Diffuse | 21 |
| Hodgkin Disease | 20 |
| Leukemia | 20 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 19 |
| Multiple Myeloma | 19 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 19 |
| Lymphoma, Follicular | 17 |
Trials
Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.